Asmita Thapa
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.
Journal: Science advances
Published: June 12, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
Journal: Cell reports
Published: May 19, 2026
Deciphering the phenotypic responses to 177Lu-based radioligand therapy to identify efficacious combinations.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 20, 2026
Impact of dietary rumen degradable protein level on growth performance, rumen fermentation, and nitrogen utilization in growing Hu sheep.
Journal: Translational animal science
Published: September 29, 2025
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion.
Journal: Cell reports
Published: May 19, 2025
The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in Scotland.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: August 29, 2023
Deoxynivalenol and Zearalenone-Synergistic or Antagonistic Agri-Food Chain Co-Contaminants?
Journal: Toxins
Published: June 21, 2021
Reduced respiratory motion artefact in constant TR multi-slice MRI of the mouse.
Journal: Magnetic resonance imaging
Published: December 05, 2018
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73.
Journal: Nature communications
Published: March 15, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026